EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Real-time Estimate Cboe BZX  -  05/25 01:00:01 pm EDT
94.99 USD   +0.48%
05/23Edwards lifesciences to present at the bernstein 38th annual strategic decisions conference
PR
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Price Target on Edwards Lifesciences to $115 From $134, Reiterates Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Edwards Lifesciences

01/18/2022 | 06:28am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
EDWARDS LIFESCIENCES CORPORATION 0.11% 94.69 Delayed Quote.-27.02%
ON SEMICONDUCTOR CORPORATION 1.71% 55.5168 Delayed Quote.-19.76%
All news about EDWARDS LIFESCIENCES CORPORATION
05/23Edwards lifesciences to present at the bernstein 38th annual strategic decisions confer..
PR
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Price Target on Edwards Lifesciences to $115 From $134, Reiterates Bu..
MT
05/16Edwards announces key events for europcr 2022
PR
05/11INSIDER SELL : Edwards Lifesciences
MT
05/04EDWARDS LIFESCIENCES CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/29INSIDER SELL : Edwards Lifesciences
MT
04/28EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition ..
AQ
04/28TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
04/28TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 5 734 M - -
Net income 2022 1 558 M - -
Net cash 2022 1 316 M - -
P/E ratio 2022 38,3x
Yield 2022 -
Capitalization 58 780 M 58 780 M -
EV / Sales 2022 10,0x
EV / Sales 2023 8,78x
Nbr of Employees 15 700
Free-Float 96,5%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 94,54 $
Average target price 125,90 $
Spread / Average Target 33,2%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors
1st jan.Capi. (M$)
EDWARDS LIFESCIENCES CORPORATION-27.02%58 780
THERMO FISHER SCIENTIFIC-16.79%214 842
DANAHER CORPORATION-23.41%180 406
INTUITIVE SURGICAL, INC.-39.22%78 393
SIEMENS HEALTHINEERS AG-17.20%65 584
BOSTON SCIENTIFIC CORPORATION-5.48%57 397